AAO-HNS GUIDELINES Bundle (free trial)

Epistaxis (Nosebleed)

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1197258

Contents of this Issue


Page 1 of 21

2 Key Points ➤ Nosebleed, also known as epistaxis, is a common problem that occurs at some point in at least 60% of people in the United States. • About 6% of people who experience nosebleeds will seek medical attention. Table 1. Applying the Nosebleed CPG: Target Patient and Practice Settings Target Patient Exclusions Practice Settings/ Encounter Type • Age ≥3 years • Nosebleed that is severe, persistent, recurrent, or affects quality of life. • Age <3 years • Nasal or nasopharyngeal tumor • Vascular malformation of the head and neck • Diagnosed bleeding disorder • Recent facial trauma • Recent sinus and/or nasal surgery • Outpatient office or clinic • Emergency department • Hospital (wards, radiolog y suites, operating rooms) • Phone call encounters • Emails/texts • Telemedicine Diagnosis Table 2. Risk Factors Associated with Nosebleed Prior nasal or sinus surgery Nasal or facial trauma Nasal cannula oxygen use Continuous positive airway pressure (CPAP) use Intranasal medication or drug use Use of medications which impair coagulation and/or platelet function Personal or family history of bleeding disorder Chronic kidney or liver disease

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Epistaxis (Nosebleed)